Virtu KCG Holdings’s Insys Therapeutics, Inc. INSY Stock Holding History

Virtu KCG Holdings’s Portfolio INSY Stock Details INSY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	$157K	Sell	12,406 -13,754	-53%	-$163K	﹤0.01%	2275
2017 Q1	$275K	Buy	26,160 +7,735	+42%	+$82.4K	0.01%	2047
2016 Q4	$170K	Sell	18,425 -8,174	-31%	-$92.3K	﹤0.01%	2680
2016 Q3	$314K	Buy	+26,599	New	+$404K	0.01%	1878
2016 Q2	–	Sell	-40,022	Closed	-$640K	–	3509
2016 Q1	$640K	Buy	+40,022	New	+$760K	0.02%	962
2015 Q3	–	Sell	-11,832	Closed	-$425K	–	4037
2015 Q2	$425K	Buy	+11,832	New	+$369K	0.01%	1637
2015 Q1	–	Sell	-11,904	Closed	-$251K	–	4172
2014 Q4	$251K	Buy	+11,904	New	+$235K	﹤0.01%	2581
2014 Q2	–	Sell	-22,742	Closed	-$470K	–	4219
2014 Q1	$470K	Buy	+22,742	New	+$451K	0.01%	2034

Other funds holding INSY

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

FHAM

Folger Hill Asset Management New York $16.5M AUM 19.96% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Virtu KCG Holdings's INSY Position: Q2 2017 in Review

Virtu KCG Holdings reduced its Insys Therapeutics, Inc. (INSY) stake by 53% in Q2 2017, selling an estimated $163K and leaving 12,406 shares worth $157K. The position accounts for ﹤0.01% of the portfolio, ranked #2275.

Virtu KCG Holdings first reported a position in INSY in Q1 2014 and has held it in 8 quarters since. The position peaked at $640K in Q1 2016. 118 funds tracked by Wall St. Rank hold INSY as of Q2 2017.

Virtu KCG Holdings held 12,406 shares of Insys Therapeutics, Inc. worth $157K as of Q2 2017.
Virtu KCG Holdings sold 13,754 Insys Therapeutics, Inc. shares in Q2 2017, an estimated $163K.
Insys Therapeutics, Inc. made up ﹤0.01% of Virtu KCG Holdings's portfolio in Q2 2017, its #2275 holding.
Virtu KCG Holdings first reported a position in Insys Therapeutics, Inc. in Q1 2014 and has held it in 8 quarters since.
Virtu KCG Holdings's Insys Therapeutics, Inc. position peaked at $640K in Q1 2016.
118 funds tracked by Wall St. Rank held Insys Therapeutics, Inc. as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.